Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
Polyethylene Terephthalate
75%
Positron Emission Tomography
42%
Fluorodeoxyglucose F 18
31%
Neonatal Infant
25%
Newborn Infection
24%
Granulocyte Macrophage Colony Stimulating Factor
20%
Granulocyte Colony Stimulating Factor
20%
Hypertriglyceridemia
20%
Clinical Significance
20%
T Cell
20%
Pediatrics
20%
Cancer in Young Adults
20%
Cohort Analysis
20%
Positron Emission Tomography-Computed Tomography
20%
Interleukin 8
20%
Sepsis
20%
Acute Lymphoblastic Leukemia
20%
Thrombopoietin
20%
Natural Killer Cell
20%
Hypopyon
20%
Computer Assisted Tomography
20%
Lymphoblastic Lymphoma
20%
Acute Lymphocytic Leukemia
20%
Neoplasm
18%
Fusion Gene
16%
Event Free Survival
12%
Bone Marrow Biopsy
12%
Neonatal Thrombocytopenia
10%
International Prognostic Index
9%
Antiinfective Agent
9%
Neutrophil
8%
Hazard Ratio
7%
Diseases
7%
Non-Hodgkin Lymphoma
6%
Colony Stimulating Factor
6%
CD3 Antigen
6%
Hyperlipidemia
6%
T Cell Receptor
6%
Attributable Risk
6%
T-Cell Lymphoma
6%
Hypercholesterolemia
6%
Intraocular Tumor
6%
Differential Diagnosis
6%
Triacylglycerol Lipase
6%
CD8 Antigen
6%
Progression Free Survival
6%
Malignant Neoplasm
6%
Clinical Trial
5%
Cytokine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diffuse Large B Cell Lymphoma
60%
Polyethylene Terephthalate
60%
Fluorodeoxyglucose F 18
23%
Clofarabine
20%
Granulocyte Macrophage Colony Stimulating Factor
20%
Acute Lymphoblastic Leukemia
20%
Newborn Infection
20%
Granulocyte Colony Stimulating Factor
20%
Hemopoietic Growth Factor
20%
Thrombopoietin
20%
Newborn Sepsis
20%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
18%
Neonatal Thrombocytopenia
10%
Small for Date Infant
10%
Colony Stimulating Factor
6%
Purine Nucleoside Derivative
5%
Toll Like Receptor 3
5%
Immunology and Microbiology
B Cell
60%
T Cell
30%
positron emission tomographic scan
24%
Granulocyte Colony-Stimulating Factor
20%
Platelet
20%
Hemopoietic Growth Factor
20%
Thrombopoietin
20%
Natural Killer Cell
20%
Artificial Intelligence
20%
T Cell Receptor
13%
Progression Free Survival
13%
CD7
10%
CD8
10%
Platelet Count
10%
CD3 Antigen
10%
Immunity
8%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
8%
Idiopathic Thrombocytopenic Purpura
5%
